Results 141 to 150 of about 26,501 (228)

Vietnamese expert consensus on the treatment of hepatocellular carcinoma with transarterial chemoembolization. [PDF]

Front Radiol
Luu VD, Tan DD, Thong PM, Khang LV, Dung LT, Binh LT, Trang NN, Cuong NN, Luan ND, Lam NL, Chau TH, Sy TV, Anh ND, Tho LD, Huy TD, Hieu DN, Son PQ, Tri LD, Huong ND, Phuong PC, Thinh NT, Thong VD, Phat HT, Duc PTH, Anh PG, Truc VHT, Trung LQ, Thao LB, Anh LT, Long TCD.   +29 more
europepmc   +1 more source

The predictive value of preoperative ultrasound contrast parameters for early recurrence after transarterial chemoembolization for hepatocellular carcinoma. [PDF]

Front Med (Lausanne)
Jin S, Wang Q, Zhu L, Teng D, Sui G, Wang H.   +5 more
europepmc   +1 more source

3. Transarterial Chemoembolization

Nihon Naika Gakkai Zasshi, 2014
openaire   +2 more sources

Transarterial Chemoembolization plus Systemic Therapy versus Transarterial Chemoembolization alone for Unresectable, Nonmetastatic Hepatocellular Carcinoma: Meta-Analysis and Trial Sequential Analysis from Randomized Controlled Trials. [PDF]

Liver Cancer
Liu J, Zhai H, Shang L, Wang P, Liu J, Wang L, You Q, Qin M, Ma Y, Shao H.   +9 more
europepmc   +1 more source

Leverage of quick-soluble gelatin microparticles in transarterial chemoembolization of canine urothelial carcinomas. [PDF]

Vet Q
Jeon S, Lee G, Kim JK, Lee N, Chang D.
europepmc   +1 more source

A multicenter pilot study of nivolumab with drug-eluting bead transarterial chemoembolization in patients with liver-limited hepatocellular carcinoma. [PDF]

ESMO Gastrointest Oncol
Harding JJ, Fitzpatrick OM, Chou JF, Yarmohammadi H, Reiss KA, Do RK, Wong P, Khalil DN, El Dika I, Ferrer C, Heffernan O, Yaqubie A, Giardina JD, D'Angelica M, Jarnagin WR, Nadolski G, Covey A, Erinjeri JP, Brown K, Soulen MC, Tan B, Capanu M, Abou-Alfa GK.   +22 more
europepmc   +1 more source

Comparison of two transarterial chemoembolization strategies for hepatocellular carcinoma.

, 2014
International audienceThis retrospective study aimed to compare the efficacy of and tolerance to two center-related conventional transarterial chemoembolization (TACE) strategies in the management of unresectable hepatocellular carcinoma (HCC)
Aho, Serge, Fagnoni, Philippe, Sautou, Valérie, Tavernier, Jerome, Vadot, Lucie, Abergel, Armand, Hillon, Patrick, Boulin, Mathieu, Chabrot, Pascal, Guiu, Boris, Boyer, Louis   +10 more
core  

Transarterial chemoembolization (TACE) with or without immune checkpoint inhibitors in unresectable hepatocellular carcinoma: a meta-analysis of randomized clinical trials. [PDF]

ESMO Gastrointest Oncol
Kim H, Felismino TC, Lício Júnior A, Almeida GR, Brito ABC.   +4 more
europepmc   +1 more source

Analysis of risk factors and prediction of prognosis in patients with primary liver cancer undergoing transarterial chemoembolization. [PDF]

Front Oncol
Lu XL, Yin LM.
europepmc   +1 more source

Dual-modality imaging with CEUS and MRI for early recurrence assessment in hepatocellular carcinoma following combined radiofrequency ablation and transarterial chemoembolization. [PDF]

Front Oncol
Jin S, Wang Q, Zhu L, Teng D, Sui G, Wang H.   +5 more
europepmc   +1 more source